Sorry, Readability was unable to parse this page for content.
Source: http://www.facebook.com/fox26houston/posts/260916117376547
tacoma narrows bridge open marriage department of justice doj dept of justice weather chicago swizz beatz
Sorry, Readability was unable to parse this page for content.
Source: http://www.facebook.com/fox26houston/posts/260916117376547
tacoma narrows bridge open marriage department of justice doj dept of justice weather chicago swizz beatz
MARANA, Arizona, Feb 19 (Reuters) - Steve Stricker and Jim Furyk joined a growing chorus of players backing the idea of the PGA Tour adopting a local rule to ignore a proposed ban on putters anchored to the body on Tuesday. American Stricker, widely regarded as one of the game's best putters, said he had changed his view after consistently opposing the use of long putters and that he would not be surprised to see the tour dig in its heels. ...
Source: http://news.yahoo.com/apple-pulls-20-consumer-technology-revenue-u-200506841.html
celtic thunder fabrice muamba collapse prometheus trailer patrice oneal shamrock slainte the quiet man
FILE - This Jan. 21, 2013 file photo shows actress Jane Lynch during the 2013 Sundance Film Festival at the Fender Music Lodge in Park City, Utah. Lynch said Wednesday, Feb. 20, she?ll be replacing Tony Award-winning actress Katie Finneran as the evil orphanage matron Miss Hannigan in the current revival of "Annie." A veteran of Chicago?s Steppenwolf Theatre Company, she will play Hannigan for eight weeks, from May 16 through July 14. (Photo by Victoria Will/Invision/AP, file)
FILE - This Jan. 21, 2013 file photo shows actress Jane Lynch during the 2013 Sundance Film Festival at the Fender Music Lodge in Park City, Utah. Lynch said Wednesday, Feb. 20, she?ll be replacing Tony Award-winning actress Katie Finneran as the evil orphanage matron Miss Hannigan in the current revival of "Annie." A veteran of Chicago?s Steppenwolf Theatre Company, she will play Hannigan for eight weeks, from May 16 through July 14. (Photo by Victoria Will/Invision/AP, file)
FILE - This Jan. 21, 2013 file photo shows actress Jane Lynch during the 2013 Sundance Film Festival at the Fender Music Lodge in Park City, Utah. Lynch said Wednesday, Feb. 20, she?ll be replacing Tony Award-winning actress Katie Finneran as the evil orphanage matron Miss Hannigan in the current revival of "Annie." A veteran of Chicago?s Steppenwolf Theatre Company, she will play Hannigan for eight weeks, from May 16 through July 14. (Photo by Victoria Will/Invision/AP, file)
NEW YORK (AP) ? Jane Lynch has something to be gleeful about ? she's about to make her Broadway debut.
The "Glee" star said Wednesday she'll be replacing Tony Award-winning actress Katie Finneran as the evil orphanage matron Miss Hannigan in the current revival of "Annie."
"I'm so thrilled I can't see straight," the actress said by phone from her home in Los Angeles. "It's a preposterous fantasy come true."
Lynch, a veteran of Chicago's Steppenwolf Theatre Company, will play Miss Hannigan for eight weeks, from May 16 through July 14. Finneran will depart to film a new NBC comedy series with Michael J. Fox.
"It's a real joy for me to step into her shoes, which are large and scare the hell out of me," said Lynch. "But it's good to be scared. It's good to jump off a cliff."
Lynch will star opposite Lilla Crawford in the title role and Anthony Warlow as Daddy Warbucks. The music by Charles Strouse with lyrics by Martin Charnin contains gems like "You're Never Fully Dressed Without a Smile," ''Tomorrow" and "It's the Hard Knock Life."
Lynch has an Emmy and Golden Globe for playing the track-suited, glee-club-hating cheerleading coach Sue Sylvester on "Glee." Her film credits include "Wreck-It Ralph," ''Three Stooges," ''The 40 Year old Virgin" and "A Mighty Wind."
She said she knows "every breath of this musical," having grown up listening to the cast album with her mother. She recalls seeing the film in the mid-1980s and adoring Carol Burnett, who played Miss Hannigan.
Lynch finds it funny that she'll go from playing a TV teacher who is fond of random acts of terror to a gin-swilling orphanage head to calls her charges "brats," denies them hot mush and threatens "your days are numbered."
"I do a lot of mean people," she said. "I'm the sweetest person you'll ever meet but I do have a fascination with that kind of cruelty that comes from a very, very soft place."
___
Online: http://www.AnnieTheMusical.com
___
Follow Mark Kennedy on Twitter at http://twitter.com/KennedyTwits
Associated Presshope solo tesla model s tesla model s act Black Ops 2 Secede ben roethlisberger
Chad Blakley / Lights Over Lapland
The northern lights vie with a waxing moon over Sweden's Abisko National Park on Monday night.
By Alan Boyle, Science Editor, NBC News
One look at SpaceWeather.com's aurora gallery will tell you that February has been a very good month for auroral displays in northern latitudes, and an upswing in solar activity promises more to come.
One of the hot spots is Sweden's Abisko National Park, which is the favorite hangout for Chad Blakley of Lights Over Lapland. "We have seen powerful auroras in the sky above Abisko for 13 nights in a row, and it looks like there are more to come!" he wrote in an email Tuesday. "Last night I witnessed one of the finest aurora displays I have seen in many months. February 2013 is turning out to be one of the best months for aurora watching I have ever seen!"
You can get a sense of how Blakley's nights have been going by taking a minute to watch Blakley's time-lapse video below. But don't stop there: I'm also including a time-lapse from Helge Mortensen, a photographer based in Tromso, Norway, and from Oli Haukur and the OZZO Photography team in Iceland.
Scandinavia, Alaska and northern Canada are all hot spots for the northern lights this time of year, even though it gets chilly at night. The auroral displays might dip farther south if we get a nice geomagnetic storm coming our way, and the solar weather outlook suggests that could happen. A new sunspot region known as AR 1678 has cropped up, and SpaceWeather.com says this region could give rise to "a significant solar flare."
Check out the usual places for space weather updates, including the National Oceanic and Atmospheric Administration's Space Weather Prediction Center as well as the center's Facebook page and its Ovation aurora forecast chart. You'll also want to keep tabs on the Canadian Space Agency's AuroraMAX website ? and the Lights Over Lapland Facebook page, where you'll find an awesome image of the aurora glowing beside a moon halo.
More auroral glories:
Alan Boyle is NBCNews.com's science editor. Connect with the Cosmic Log community by "liking" the log's?Facebook page, following?@b0yle on Twitter?and adding the?Cosmic Log page?to your Google+ presence. To keep up with Cosmic Log as well as NBCNews.com's other stories about science and space, sign up for the Tech & Science newsletter, delivered to your email in-box every weekday. You can also check out?"The Case for Pluto,"?my book about the controversial dwarf planet and the search for new worlds.
big brother Shakira iOS 6 bank of america Yunel Escobar Eye Black Cruel Summer Endeavor
Sorry, Readability was unable to parse this page for content.
Source: http://calendar.vanderbilt.edu/calendar/2013/02/19/vanderbilt-baseball-at-belmont.185524
Joe Webb Fiesta Bowl Jeanie Buss NFL playoff schedule 2013 biggest loser Bronson Pelletier andy reid
Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
OAK BROOK, Ill. Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
"CCTA should be considered as an appropriate first- line test for patients with atypical chest pain and suspected but not confirmed coronary artery disease," said the study's lead author, Jonathon Leipsic, M.D., FRCPC, from the University of British Columbia in Vancouver.
Heart disease is the leading cause of death in the U.S., according to the Centers for Disease Control and Prevention. Treatment often involves addressing modifiable cardiovascular risk factors such as elevated cholesterol, high blood pressure, diabetes and smoking. However, some risk factors, like family history, are not modifiable, and no risk models exist to help guide clinicians to identify those symptomatic patients without cardiac risk factors who are at an increased risk of death and myocardial infarction.
"This scenario, where patients are symptomatic but have no cardiac risk factors, comes up often in clinical practice," Dr. Leipsic said. "We lack a good tool to stratify these patients into risk groups."
CCTA is a noninvasive test that has shown high accuracy for the diagnosis or exclusion of coronary artery disease in individuals. However, referral for patients with suspected coronary artery disease is often based on clinical risk factor scoring. Less is known about the prognostic value of CCTA in individuals with no medically modifiable risk factors.
In the first study of its kind, Dr. Leipsic and colleagues correlated CCTA findings with the risk of major adverse cardiac events in 5,262 patients with suspected coronary artery disease but no medically modifiable risk factors. They culled the data from the Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter (CONFIRM) registry.
After an average follow-up of 2.3 years, 104 patients had experienced a major adverse cardiovascular event. The researchers identified a high prevalence of coronary artery disease in the study group, despite the absence of modifiable risk factors. More than one-quarter of the patients had non-obstructive disease or disease related to the buildup of plaque in the arteries, and another 12 percent had obstructive disease with a greater than 50 percent narrowing in a coronary artery.
"We found that patients with narrowing of the coronary arteries on CT had a much higher risk of an adverse cardiac event," Dr. Leipsic said. "This was true even for those without a family history of heart disease."
Both symptomatic and asymptomatic patients with obstructive disease faced an increased risk for a major cardiac event. In contrast, the absence of coronary artery disease on CCTA was associated with a very low risk of a major event.
The findings highlight the need for refinement in the evaluation of individuals who may be missed by traditional methods of coronary artery disease evaluation.
"If a patient shows up with vague symptoms and no medically modifiable risk factors, doctors often dismiss them or do a treadmill test, which won't identify atherosclerosis and only has a modest sensitivity for detecting obstructive disease," Dr. Leipsic said.
CCTA could help address this problem, Dr. Leipsic added, by helping to diagnose or rule out coronary artery disease and identifying those who may benefit from more intensive therapy.
The researchers continue to study the CONFIRM data with the aim to learn more about the relationship between plaque and heart attacks and the longer-term outlook for patients with coronary artery disease.
"We are now collecting data to determine the prognostic value of CCTA after five years or more of follow-up, which will be very important for the field," Dr. Leipsic said.
###
"Cardiovascular Risk Among Stable Individuals with Suspected Coronary Artery Disease But No Medically Modifiable Risk Factors: Results from an International Multicenter Study of 5262 Patients." Collaborating with Dr. Leipsic were Carolyn M. Taylor, M.D., Gilat Grunau, Brett G. Heilbron, M.B.B.S., G.B.J. Mancini, M.D., Stephan Achenbach, M.D., Mouaz Al-Mallah, M.D., Daniel S. Berman, M.D., Matthew J. Budoff, M.D., Filippo Cademartiri, M.D., Ph.D., Tracy Q. Callister, M.D., Hyuk-Jae Chang, M.D., Victor Y. Cheng, M.D., Kavitha Chinnaiyan, M.D., Benjamin J.W. Chow, M.D., Augustin Delago, M.D., Martin Hadamitzky, M.D., Joerg Hausleiter, M.D., Ricardo Cury, M.D., Gudrun Feuchtner, M.D., Yong-Jin Kim, M.D., Philipp A. Kaufmann, M.D., Fay Y. Lin, M.D., Erica Maffei, M.D., Gilbert Raff, M.D., Leslee J. Shaw, Ph.D., Todd C. Villines, M.D., and James K. Min, M.D.
Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc. (http://radiology.rsna.org/)
RSNA is an association of more than 51,000 radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)
For patient-friendly information on CT angiography, visit RadiologyInfo.org.
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Contact: Linda Brooks
lbrooks@rsna.org
630-590-7762
Radiological Society of North America
OAK BROOK, Ill. Coronary computed tomography angiography (CCTA) is an effective tool for determining the risk of heart attacks and other adverse cardiac events in patients with suspected coronary artery disease but no treatable risk factors, such as high cholesterol or high blood pressure, according to a new study published online in the journal Radiology.
"CCTA should be considered as an appropriate first- line test for patients with atypical chest pain and suspected but not confirmed coronary artery disease," said the study's lead author, Jonathon Leipsic, M.D., FRCPC, from the University of British Columbia in Vancouver.
Heart disease is the leading cause of death in the U.S., according to the Centers for Disease Control and Prevention. Treatment often involves addressing modifiable cardiovascular risk factors such as elevated cholesterol, high blood pressure, diabetes and smoking. However, some risk factors, like family history, are not modifiable, and no risk models exist to help guide clinicians to identify those symptomatic patients without cardiac risk factors who are at an increased risk of death and myocardial infarction.
"This scenario, where patients are symptomatic but have no cardiac risk factors, comes up often in clinical practice," Dr. Leipsic said. "We lack a good tool to stratify these patients into risk groups."
CCTA is a noninvasive test that has shown high accuracy for the diagnosis or exclusion of coronary artery disease in individuals. However, referral for patients with suspected coronary artery disease is often based on clinical risk factor scoring. Less is known about the prognostic value of CCTA in individuals with no medically modifiable risk factors.
In the first study of its kind, Dr. Leipsic and colleagues correlated CCTA findings with the risk of major adverse cardiac events in 5,262 patients with suspected coronary artery disease but no medically modifiable risk factors. They culled the data from the Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter (CONFIRM) registry.
After an average follow-up of 2.3 years, 104 patients had experienced a major adverse cardiovascular event. The researchers identified a high prevalence of coronary artery disease in the study group, despite the absence of modifiable risk factors. More than one-quarter of the patients had non-obstructive disease or disease related to the buildup of plaque in the arteries, and another 12 percent had obstructive disease with a greater than 50 percent narrowing in a coronary artery.
"We found that patients with narrowing of the coronary arteries on CT had a much higher risk of an adverse cardiac event," Dr. Leipsic said. "This was true even for those without a family history of heart disease."
Both symptomatic and asymptomatic patients with obstructive disease faced an increased risk for a major cardiac event. In contrast, the absence of coronary artery disease on CCTA was associated with a very low risk of a major event.
The findings highlight the need for refinement in the evaluation of individuals who may be missed by traditional methods of coronary artery disease evaluation.
"If a patient shows up with vague symptoms and no medically modifiable risk factors, doctors often dismiss them or do a treadmill test, which won't identify atherosclerosis and only has a modest sensitivity for detecting obstructive disease," Dr. Leipsic said.
CCTA could help address this problem, Dr. Leipsic added, by helping to diagnose or rule out coronary artery disease and identifying those who may benefit from more intensive therapy.
The researchers continue to study the CONFIRM data with the aim to learn more about the relationship between plaque and heart attacks and the longer-term outlook for patients with coronary artery disease.
"We are now collecting data to determine the prognostic value of CCTA after five years or more of follow-up, which will be very important for the field," Dr. Leipsic said.
###
"Cardiovascular Risk Among Stable Individuals with Suspected Coronary Artery Disease But No Medically Modifiable Risk Factors: Results from an International Multicenter Study of 5262 Patients." Collaborating with Dr. Leipsic were Carolyn M. Taylor, M.D., Gilat Grunau, Brett G. Heilbron, M.B.B.S., G.B.J. Mancini, M.D., Stephan Achenbach, M.D., Mouaz Al-Mallah, M.D., Daniel S. Berman, M.D., Matthew J. Budoff, M.D., Filippo Cademartiri, M.D., Ph.D., Tracy Q. Callister, M.D., Hyuk-Jae Chang, M.D., Victor Y. Cheng, M.D., Kavitha Chinnaiyan, M.D., Benjamin J.W. Chow, M.D., Augustin Delago, M.D., Martin Hadamitzky, M.D., Joerg Hausleiter, M.D., Ricardo Cury, M.D., Gudrun Feuchtner, M.D., Yong-Jin Kim, M.D., Philipp A. Kaufmann, M.D., Fay Y. Lin, M.D., Erica Maffei, M.D., Gilbert Raff, M.D., Leslee J. Shaw, Ph.D., Todd C. Villines, M.D., and James K. Min, M.D.
Radiology is edited by Herbert Y. Kressel, M.D., Harvard Medical School, Boston, Mass., and owned and published by the Radiological Society of North America, Inc. (http://radiology.rsna.org/)
RSNA is an association of more than 51,000 radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)
For patient-friendly information on CT angiography, visit RadiologyInfo.org.
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2013-02/rson-cah021213.php
BETHLEHEM, West Bank (AP) ? Palestinians are holding demonstrations across the West Bank in a show of solidarity with prisoners on hunger strike in Israeli jails.
In Bethlehem, Israeli forces dispersed several dozen activists who blocked a road on Monday. There were no reports of injuries. In the West Bank city of Ramallah, about 50 activists demonstrated at a U.N. office.
The hunger strikers, who include a man who is said to be in critical condition after staging an on-again, off-again strike for more than 200 days, say they are being unfairly held and are demanding to be released.
Israel is holding some 4,500 Palestinians for charges ranging from throwing stones to undertaking deadly militant attacks.
Their incarceration is a sensitive issue for Palestinians, who see them as heroes of the Palestinian liberation struggle.
Source: http://news.yahoo.com/palestinians-rally-prisoners-held-israel-102841842.html
rosie o donnell soda bread recipe vanderbilt evan mathis staff sgt. robert bales jason russell norfolk state